Literature DB >> 23043967

Long-term effect of repeated lidocaine injections into the external oblique for upper camptocormia in Parkinson's disease.

Yoshihiko Furusawa1, Yohei Mukai, Tomoya Kawazoe, Terunori Sano, Harumasa Nakamura, Chikako Sakamoto, Yasuyuki Iwata, Mizuki Wakita, Yasuhiro Nakata, Kohei Kamiya, Yoko Kobayashi, Takashi Sakamoto, Yoshihisa Takiyama, Miho Murata.   

Abstract

BACKGROUND: Parkinson's disease (PD) is occasionally complicated by camptocormia. In a previous study, we classified camptocormia into upper and lower types based on the inflection point, and reported that lidocaine injection into the external oblique muscle, but not into the internal oblique or rectus abdomen, improved upper camptocormia in PD. The effect of a single lidocaine injection disappeared over a period of few days. In this study, we used repeated lidocaine injections into the external oblique for 4-5 days and evaluated the effects of such treatment for up to 90 days.
METHODS: The study subjects were 12 patients with PD and upper camptocormia who were treated with repeated lidocaine injections into the bilateral external oblique followed by rehabilitation. The effect of treatment was evaluated by measuring the angle of truncal flexion before and after the injection. Patients who showed improvement with repeated injections were evaluated during a 90-day period.
RESULTS: Eight out of 12 patients showed significant improvement in posture after a single lidocaine injection. However, the effect subsided several days after treatment. Repeated injections produced long-term improvement in 9 out of 12 patients, which was maintained during the 90-day observation period in eight of these patients.
CONCLUSIONS: Our results showed that repeated lidocaine injections into the external oblique improved upper camptocormia, and that the effect was maintained in the majority of patients during the 90-day observation period, indicating that repeated lidocaine injections into the external oblique have therapeutic effect on upper camptocormia in patients with Parkinson's disease. Crown
Copyright © 2012. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23043967     DOI: 10.1016/j.parkreldis.2012.09.008

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  10 in total

Review 1.  Managing Gait, Balance, and Posture in Parkinson's Disease.

Authors:  Bettina Debû; Clecio De Oliveira Godeiro; Jarbas Correa Lino; Elena Moro
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-06       Impact factor: 5.081

Review 2.  Camptocormia in Parkinson's disease: definition, epidemiology, pathogenesis and treatment modalities.

Authors:  Prachaya Srivanitchapoom; Mark Hallett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-04-20       Impact factor: 10.154

3.  Treatment of camptocormia with continuous subcutaneous infusions of apomorphine: 1-year prospective pilot study.

Authors:  Katerina Mensikova; Michaela Kaiserova; Miroslav Vastik; Sandra Kurcova; Petr Kanovsky
Journal:  J Neural Transm (Vienna)       Date:  2014-08-19       Impact factor: 3.575

4.  The 2022 On-site Padua Days on Muscle and Mobility Medicine hosts the University of Florida Institute of Myology and the Wellstone Center, March 30 - April 3, 2022 at the University of Padua and Thermae of Euganean Hills, Padua, Italy: The collection of abstracts.

Authors:  H Lee Sweeney; Stefano Masiero; Ugo Carraro
Journal:  Eur J Transl Myol       Date:  2022-03-10

Review 5.  Muscle Selection for Focal Limb Dystonia.

Authors:  Barbara Illowsky Karp; Katharine Alter
Journal:  Toxins (Basel)       Date:  2017-12-29       Impact factor: 4.546

6.  Do Upper and Lower Camptocormias Affect Gait and Postural Control in Patients with Parkinson's Disease? An Observational Cross-Sectional Study.

Authors:  Christian Geroin; Marialuisa Gandolfi; Isacco Maddalena; Nicola Smania; Michele Tinazzi
Journal:  Parkinsons Dis       Date:  2019-07-24

Review 7.  Camptocormia: Etiology, diagnosis, and treatment response.

Authors:  Farwa Ali; Joseph Y Matsumoto; Anhar Hassan
Journal:  Neurol Clin Pract       Date:  2018-06

8.  Clinical Definition of Camptocormia in Parkinson's Disease.

Authors:  Nils G Margraf; Oliver Granert; Julia Hampel; Arne Wrede; Walter J Schulz-Schaeffer; Günther Deuschl
Journal:  Mov Disord Clin Pract       Date:  2016-10-11

9.  Lidocaine injections and neck corset wearing improve dropped head syndrome in Parkinson's disease and related disorders.

Authors:  Yohei Mukai; Yoshihiko Furusawa; Yuko Morimoto; Yuka Hama; Tomoya Kawazoe; Yuji Saitoh; Takashi Sakamoto; Yuji Takahashi; Miho Murata
Journal:  Clin Park Relat Disord       Date:  2019-10-26

Review 10.  Pathophysiological Concepts and Treatment of Camptocormia.

Authors:  N G Margraf; A Wrede; G Deuschl; W J Schulz-Schaeffer
Journal:  J Parkinsons Dis       Date:  2016-06-16       Impact factor: 5.568

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.